Residents

ExCellThera Inc.

ExCellThera Inc.

ExCellThera Inc. is a clinical stage biotechnology company developing safe and effective stem cell therapies that will improve the treatment of blood cancers and non-malignant disease. ExCellThera’s solution rapidly expands stem cells from umbilical cord blood in vitro, thereby increasing access to transplants for patients who do not have a matched donor and introducing the possibility for corrective gene therapies. The company’s lead product is currently in clinical trial and leverages two proprietary technologies: the newly discovered UM171 molecule, which rapidly expands blood stem cells; and a fed-batch bioreactor system, that safely and reproducibly generates expanded cell products in an easily scalable and low cost manner.
 

Area of focus: 
Oncology
Commencement date: 
02/01/2017

Share